Vision RT is a pioneering Radiation Oncology technology company based in London, UK. They specialize in Surface Guided Radiation Therapy (SGRT), a contact-free technology that ensures the safe delivery of radiation therapy to cancer patients. Vision RT's real-time responsive patient monitoring systems have set new standards in patient safety, comfort, and efficacy in Radiation Oncology.

Founded in 2001, Vision RT's mission is to develop cutting-edge technology for SGRT, with the aim of enhancing treatment efficacy and efficiency while prioritizing patient comfort. Over the years, they have collaborated with leading cancer centers and equipment vendors worldwide. Their video-based tracking technology is now considered the standard of care in surface-guided radiotherapy, with over 2000 installations globally.

With headquarters in London, Vision RT has a global presence, employing over 250 staff across various locations, including the US, Poland, India, UAE, and Australia. As part of the Demant A/S family, which is a leading Danish Medtech investor, Vision RT is backed by a long-term investment perspective. Their goal is to provide world-class solutions to cancer clinics worldwide and promote the extensive benefits of SGRT through education and community engagement